Mar 17, 2020
The Global Syphilis Testing Market is expected to grow by USD 0.42 bn during 2020-2024, progressing at a CAGR of 2% during the forecast period
Dec 18, 2019
U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy
May 29, 2019
Cepheid Receives FDA Clearance for Extragenital Claims for Xpert® CT/NG Test
May 23, 2019
FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea
Apr 23, 2019
Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora
Nov 08, 2018
Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy
Nov 07, 2018
Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Sep 25, 2018
Rise of syphilis in newborns another symptom of nation's STD crisis
Apr 16, 2018
Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems
Apr 09, 2018
New Survey: False Beliefs about Sexual Risk, Poor Physician-Patient Communication May Impede STD Screening in Young Women
Feb 09, 2018
Global Syphilis Testing Market Report 2018 Featuring Key Vendors - Abbott, Beckman Coulter, Bio-Rad Laboratories, F. Hoffmann-La Roche & Siemens Healthcare
Jan 31, 2018
CAS Group Announces Glass Lewis Recommendation That Aviragen Stockholders Vote AGAINST Merger and Emphasizes Value of Teslexivir (BTA074) Program
Sep 26, 2017
STDs at record high, indicating urgent need for prevention